Apolipoprotein E Genotype Affects Size of ApoE Complexes in Cerebrospinal Fluid

Koch, 2001, Characterization of four lipoprotein classes in human cerebrospinal fluid, J Lipid Res, 42, 1143, 10.1016/S0022-2275(20)31605-9

10.1073/pnas.76.9.4646

10.1172/JCI112130

Pitas, 1987, Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins, Biochim Biophys Acta, 917, 148, 10.1016/0005-2760(87)90295-5

LaDu, 1998, Nascent astrocyte particles differ from lipoproteins in CSF, J Neurochem, 70, 2070, 10.1046/j.1471-4159.1998.70052070.x

10.1016/S0197-0186(01)00049-3

10.1172/JCI6179

10.1186/1750-1326-8-13

10.1074/jbc.274.42.30001

10.1038/nrneurol.2012.263

10.1046/j.1471-4159.2000.0741008.x

10.1002/jnr.22073

10.1186/s13024-015-0001-3

10.1001/jamaneurol.2015.1285

10.1001/jama.2015.4668

10.1016/j.bbacli.2015.01.005

10.1258/acb.2010.010100

10.1523/JNEUROSCI.5198-13.2014

Rainwater, 1997, Characterization of a composite gradient gel for the electrophoretic separation of lipoproteins, J Lipid Res, 38, 1261, 10.1016/S0022-2275(20)37207-2

10.1074/mcp.M900526-MCP200

10.1073/pnas.83.4.1125

10.1073/pnas.83.4.1130

10.1111/j.1749-6632.2002.tb04852.x

10.1016/S0197-0186(03)00112-8

10.1016/j.febslet.2012.12.003

Arendt, 1997, Plastic neuronal remodeling is impaired in patients with Alzheimer’s disease carrying apolipoprotein epsilon 4 allele, J Neurosci, 17, 516, 10.1523/JNEUROSCI.17-02-00516.1997

10.1006/nbdi.2001.0401

10.1038/jcbfm.2010.99

10.1016/j.bbrc.2009.04.153

10.1006/exnr.1997.6710

10.1074/jbc.271.47.30121

10.1126/science.8171342

10.1074/jbc.M407962200

10.1074/jbc.M504513200

10.1074/jbc.M508780200

10.1002/humu.21076

Yassine, 2016, ABCA1-mediated cholesterol efflux capacity to cerebrospinal fluid is reduced in patients with mild cognitive impairment and Alzheimer’s disease, J Am Heart Assoc, 5, 1, 10.1161/JAHA.115.002886

10.1126/science.1217697

10.1172/JCI33622

10.1016/j.neuron.2008.04.010

10.1002/ana.20730

10.1016/j.biopsych.2009.01.027

10.1016/S1474-4422(03)00530-1

10.1038/nrneurol.2010.4

10.1056/NEJMoa1202753

10.1093/hmg/dds296

10.1016/j.neurobiolaging.2015.09.009